| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | exogenous lipid antigen binding | 1.01e-04 | 5 | 64 | 2 | GO:0030884 | |
| GeneOntologyMolecularFunction | endogenous lipid antigen binding | 1.01e-04 | 5 | 64 | 2 | GO:0030883 | |
| GeneOntologyMolecularFunction | lipid antigen binding | 1.50e-04 | 6 | 64 | 2 | GO:0030882 | |
| GeneOntologyMolecularFunction | lipopeptide binding | 4.48e-04 | 10 | 64 | 2 | GO:0071723 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 7.71e-04 | 13 | 64 | 2 | GO:0008046 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 1.26e-07 | 270 | 63 | 9 | GO:0007160 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | OTOA PCSK5 PIK3CB L1CAM CCDC80 LIMCH1 STRC APOD ADAM8 STRCP1 | 4.31e-07 | 410 | 63 | 10 | GO:0031589 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by trans-synaptic complex | 4.40e-06 | 11 | 63 | 3 | GO:0099545 | |
| GeneOntologyBiologicalProcess | regulation of integrin activation | 2.98e-05 | 20 | 63 | 3 | GO:0033623 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation, endogenous lipid antigen via MHC class Ib | 9.13e-05 | 5 | 63 | 2 | GO:0048006 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell-matrix adhesion | 9.13e-05 | 5 | 63 | 2 | GO:2000097 | |
| GeneOntologyBiologicalProcess | retrograde trans-synaptic signaling by trans-synaptic protein complex | 9.13e-05 | 5 | 63 | 2 | GO:0098942 | |
| GeneOntologyBiologicalProcess | integrin activation | 9.38e-05 | 29 | 63 | 3 | GO:0033622 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | 1.24e-04 | 254 | 63 | 6 | GO:0010810 | |
| GeneOntologyBiologicalProcess | corpus callosum development | 1.39e-04 | 33 | 63 | 3 | GO:0022038 | |
| GeneOntologyBiologicalProcess | amide metabolic process | 1.57e-04 | 511 | 63 | 8 | GO:0043603 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation, exogenous lipid antigen via MHC class Ib | 1.91e-04 | 7 | 63 | 2 | GO:0048007 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of lipid antigen via MHC class Ib | 1.91e-04 | 7 | 63 | 2 | GO:0048003 | |
| GeneOntologyBiologicalProcess | smooth muscle cell-matrix adhesion | 1.91e-04 | 7 | 63 | 2 | GO:0061302 | |
| GeneOntologyCellularComponent | dendrite | EPHB2 PCSK5 STRN3 L1CAM ELOVL5 NLGN1 APOD ATP1A2 TENM2 ALOX5 OPRD1 | 5.30e-05 | 858 | 64 | 11 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | EPHB2 PCSK5 STRN3 L1CAM ELOVL5 NLGN1 APOD ATP1A2 TENM2 ALOX5 OPRD1 | 5.42e-05 | 860 | 64 | 11 | GO:0097447 |
| GeneOntologyCellularComponent | cell surface | EPHB2 OTOA CD1C CD1E L1CAM NLGN1 STRC ATP1A2 ADAM8 IGSF3 STRCP1 | 5.05e-04 | 1111 | 64 | 11 | GO:0009986 |
| GeneOntologyCellularComponent | dense core granule | 6.76e-04 | 56 | 64 | 3 | GO:0031045 | |
| GeneOntologyCellularComponent | 9+2 non-motile cilium | 8.20e-04 | 14 | 64 | 2 | GO:0097732 | |
| GeneOntologyCellularComponent | kinocilium | 8.20e-04 | 14 | 64 | 2 | GO:0060091 | |
| GeneOntologyCellularComponent | dendritic spine | 8.72e-04 | 242 | 64 | 5 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 9.56e-04 | 247 | 64 | 5 | GO:0044309 | |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB2 PCSK5 STRN3 L1CAM ELOVL5 NLGN1 APOD ATP1A2 TENM2 ALOX5 OPRD1 | 1.15e-03 | 1228 | 64 | 11 | GO:0036477 |
| GeneOntologyCellularComponent | interstitial matrix | 1.22e-03 | 17 | 64 | 2 | GO:0005614 | |
| GeneOntologyCellularComponent | cell body | 1.99e-03 | 929 | 64 | 9 | GO:0044297 | |
| GeneOntologyCellularComponent | stereocilium tip | 2.05e-03 | 22 | 64 | 2 | GO:0032426 | |
| Domain | Stereocilin-rel | 3.25e-05 | 3 | 62 | 2 | IPR026664 | |
| Domain | Peptidase_S8_Asp-AS | 1.61e-04 | 6 | 62 | 2 | IPR023827 | |
| Domain | MHC_I_3 | 1.61e-04 | 6 | 62 | 2 | PF16497 | |
| Domain | PrprotnconvertsP | 2.25e-04 | 7 | 62 | 2 | IPR002884 | |
| Domain | P_proprotein | 2.25e-04 | 7 | 62 | 2 | PF01483 | |
| Domain | S8_pro-domain | 2.25e-04 | 7 | 62 | 2 | IPR032815 | |
| Domain | - | 2.25e-04 | 7 | 62 | 2 | 3.30.70.850 | |
| Domain | S8_pro-domain | 2.25e-04 | 7 | 62 | 2 | PF16470 | |
| Domain | Peptidase_S8_His-AS | 3.85e-04 | 9 | 62 | 2 | IPR022398 | |
| Domain | Peptidase_S8_Ser-AS | 3.85e-04 | 9 | 62 | 2 | IPR023828 | |
| Domain | Peptidase_S8_subtilisin-rel | 4.80e-04 | 10 | 62 | 2 | IPR015500 | |
| Domain | SUBTILASE_ASP | 4.80e-04 | 10 | 62 | 2 | PS00136 | |
| Domain | SUBTILASE_HIS | 4.80e-04 | 10 | 62 | 2 | PS00137 | |
| Domain | SUBTILASE_SER | 4.80e-04 | 10 | 62 | 2 | PS00138 | |
| Domain | - | 5.85e-04 | 11 | 62 | 2 | 3.40.50.200 | |
| Domain | Peptidase_S8/S53_dom | 5.85e-04 | 11 | 62 | 2 | IPR000209 | |
| Domain | Peptidase_S8 | 5.85e-04 | 11 | 62 | 2 | PF00082 | |
| Domain | Propept_inh | 1.43e-03 | 17 | 62 | 2 | IPR009020 | |
| Domain | Furin_repeat | 1.60e-03 | 18 | 62 | 2 | IPR006212 | |
| Domain | FU | 1.60e-03 | 18 | 62 | 2 | SM00261 | |
| Domain | - | 1.84e-03 | 73 | 62 | 3 | 2.60.120.260 | |
| Domain | - | 2.85e-03 | 24 | 62 | 2 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 2.85e-03 | 24 | 62 | 2 | IPR011161 | |
| Domain | WD40_repeat_dom | 3.04e-03 | 297 | 62 | 5 | IPR017986 | |
| Domain | Ephrin_rec_like | 3.10e-03 | 25 | 62 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 3.10e-03 | 25 | 62 | 2 | IPR011641 | |
| Domain | FN3 | 3.32e-03 | 185 | 62 | 4 | SM00060 | |
| Domain | Galactose-bd-like | 3.77e-03 | 94 | 62 | 3 | IPR008979 | |
| Domain | FN3 | 4.31e-03 | 199 | 62 | 4 | PS50853 | |
| Domain | FN3_dom | 5.12e-03 | 209 | 62 | 4 | IPR003961 | |
| Domain | IG_LIKE | 5.67e-03 | 491 | 62 | 6 | PS50835 | |
| Domain | - | 6.23e-03 | 663 | 62 | 7 | 2.60.40.10 | |
| Domain | Ig-like_dom | 6.37e-03 | 503 | 62 | 6 | IPR007110 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 11687802 | ||
| Pubmed | Single-nucleotide polymorphisms of the proprotein convertase subtilisin/ kexin type 5 (PCSK5) gene. | 3.33e-06 | 2 | 64 | 2 | 11776387 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 34910522 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12529374 | ||
| Pubmed | 3.97e-06 | 17 | 64 | 3 | 20856818 | ||
| Pubmed | Cochlear outer hair cell horizontal top connectors mediate mature stereocilia bundle mechanics. | 9.99e-06 | 3 | 64 | 2 | 30801007 | |
| Pubmed | Disruption of the aortic elastic lamina and medial calcification share genetic determinants in mice. | 9.99e-06 | 3 | 64 | 2 | 20031637 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 11459796 | ||
| Pubmed | Stereocilin-deficient mice reveal the origin of cochlear waveform distortions. | 2.00e-05 | 4 | 64 | 2 | 18849963 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 3.21e-05 | 1105 | 64 | 10 | 35748872 | |
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 3097645 | ||
| Pubmed | A physical map linking the five CD1 human thymocyte differentiation antigen genes. | 3.32e-05 | 5 | 64 | 2 | 2583117 | |
| Pubmed | CD1 genotyping of patients with Mycobacterium malmoense pulmonary disease. | 3.32e-05 | 5 | 64 | 2 | 11580851 | |
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 10488738 | ||
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 23677998 | ||
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 15032598 | ||
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 24920589 | ||
| Pubmed | Distribution of EphB receptors and ephrin-B1 in the developing vertebrate spinal cord. | 4.98e-05 | 6 | 64 | 2 | 16786562 | |
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 26148571 | ||
| Pubmed | Sek4 and Nuk receptors cooperate in guidance of commissural axons and in palate formation. | 4.98e-05 | 6 | 64 | 2 | 8947026 | |
| Pubmed | 5.32e-05 | 529 | 64 | 7 | 14621295 | ||
| Pubmed | 6.96e-05 | 7 | 64 | 2 | 10409610 | ||
| Pubmed | 6.96e-05 | 7 | 64 | 2 | 7819324 | ||
| Pubmed | EphB regulates L1 phosphorylation during retinocollicular mapping. | 6.96e-05 | 7 | 64 | 2 | 22579729 | |
| Pubmed | 6.96e-05 | 7 | 64 | 2 | 22103419 | ||
| Pubmed | Identification of NPM-ALK interacting proteins by tandem mass spectrometry. | 9.09e-05 | 47 | 64 | 3 | 14968112 | |
| Pubmed | 9.27e-05 | 8 | 64 | 2 | 17884558 | ||
| Pubmed | 9.27e-05 | 8 | 64 | 2 | 7782070 | ||
| Pubmed | Stereocilin connects outer hair cell stereocilia to one another and to the tectorial membrane. | 9.27e-05 | 8 | 64 | 2 | 21165971 | |
| Pubmed | Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. | 9.27e-05 | 8 | 64 | 2 | 9885250 | |
| Pubmed | 9.27e-05 | 8 | 64 | 2 | 25953347 | ||
| Pubmed | The activation and physiological functions of the proprotein convertases. | 1.19e-04 | 9 | 64 | 2 | 18343183 | |
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 18367611 | ||
| Pubmed | The prohormone theory and the proprotein convertases: it is all about serendipity. | 1.19e-04 | 9 | 64 | 2 | 21805236 | |
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 21805237 | ||
| Pubmed | The biology and therapeutic targeting of the proprotein convertases. | 1.19e-04 | 9 | 64 | 2 | 22679642 | |
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 23775089 | ||
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 8698813 | ||
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 10683176 | ||
| Pubmed | 1.49e-04 | 10 | 64 | 2 | 16163737 | ||
| Pubmed | 1.49e-04 | 10 | 64 | 2 | 1964443 | ||
| Pubmed | Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. | 1.54e-04 | 56 | 64 | 3 | 9455484 | |
| Pubmed | Clarin-2 is essential for hearing by maintaining stereocilia integrity and function. | 1.81e-04 | 11 | 64 | 2 | 31448880 | |
| Pubmed | 1.81e-04 | 11 | 64 | 2 | 31776257 | ||
| Pubmed | Ephrin-B1 regulates axon guidance by reverse signaling through a PDZ-dependent mechanism. | 1.81e-04 | 11 | 64 | 2 | 19515977 | |
| Pubmed | Genetic mapping of the mouse X chromosome in the region homologous to human Xq27-Xq28. | 2.99e-04 | 14 | 64 | 2 | 1674728 | |
| Pubmed | A trans-eQTL network regulates osteoclast multinucleation and bone mass. | 2.99e-04 | 14 | 64 | 2 | 32553114 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 3.38e-04 | 1201 | 64 | 9 | 35696571 | |
| Pubmed | 3.84e-04 | 730 | 64 | 7 | 34857952 | ||
| Pubmed | Screening for replication of genome-wide SNP associations in sporadic ALS. | 3.93e-04 | 16 | 64 | 2 | 18987618 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 4.03e-04 | 736 | 64 | 7 | 29676528 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | 4.66e-04 | 754 | 64 | 7 | 33060197 | |
| Pubmed | 5.00e-04 | 18 | 64 | 2 | 16854408 | ||
| Pubmed | Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality. | 5.86e-04 | 207 | 64 | 4 | 31056398 | |
| Pubmed | 6.29e-04 | 211 | 64 | 4 | 7566098 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 6.43e-04 | 91 | 64 | 3 | 28558017 | |
| Pubmed | Thalamic afferents influence cortical progenitors via ephrin A5-EphA4 interactions. | 8.23e-04 | 23 | 64 | 2 | 25480914 | |
| Pubmed | OTUB1 modulates c-IAP1 stability to regulate signalling pathways. | 8.96e-04 | 24 | 64 | 2 | 23524849 | |
| Pubmed | Ca2+ homeostasis maintained by TMCO1 underlies corpus callosum development via ERK signaling. | 1.05e-03 | 26 | 64 | 2 | 35927240 | |
| Pubmed | 1.13e-03 | 638 | 64 | 6 | 31182584 | ||
| Pubmed | Morphology-based mammalian stem cell tests reveal potential developmental toxicity of donepezil. | 1.14e-03 | 27 | 64 | 2 | 25269881 | |
| Pubmed | 1.22e-03 | 28 | 64 | 2 | 8944226 | ||
| Pubmed | Evidence that the transcriptional repressor ICER is regulated via the N-end rule for ubiquitination. | 1.22e-03 | 28 | 64 | 2 | 35227662 | |
| Pubmed | Regulation of meiotic telomere dynamics through membrane fluidity promoted by AdipoR2-ELOVL2. | 1.31e-03 | 29 | 64 | 2 | 38485951 | |
| Pubmed | 1.33e-03 | 117 | 64 | 3 | 17145500 | ||
| Pubmed | The transcription factor gene Nfib is essential for both lung maturation and brain development. | 1.40e-03 | 30 | 64 | 2 | 15632069 | |
| Pubmed | Compensatory Actions of Ldb Adaptor Proteins During Corticospinal Motor Neuron Differentiation. | 1.70e-03 | 33 | 64 | 2 | 26830346 | |
| Pubmed | 1.70e-03 | 276 | 64 | 4 | 28319085 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 1.70e-03 | 942 | 64 | 7 | 31073040 | |
| Cytoband | 1q22-q23 | 1.48e-04 | 13 | 64 | 2 | 1q22-q23 | |
| Cytoband | 15q15.3 | 5.62e-04 | 25 | 64 | 2 | 15q15.3 | |
| GeneFamily | Proprotein convertase subtilisin/kexin family | 2.46e-04 | 9 | 48 | 2 | 973 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-07 | 186 | 64 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.92e-07 | 187 | 64 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.41e-07 | 192 | 64 | 6 | 2c69f3f388b69fb1c1968c923cdbab90658883dd | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.41e-07 | 192 | 64 | 6 | d5a7b546ebfb2e757dd9c64cb1b651f6ed0e0fc7 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_12|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.68e-07 | 118 | 64 | 5 | f0f40a0165156e3fc1584480b473b0e84e10d2cc | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_12|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.00e-07 | 119 | 64 | 5 | a6b359e7aafcc197f53eb5e19c3a905bc09497bb | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.36e-06 | 168 | 64 | 5 | 3fe432267656aff81b6d92c18d1b6fc0cde73d6a | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.32e-06 | 175 | 64 | 5 | 1b35acece23712ab7e3f92d9d68266efd38b3ef5 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.32e-06 | 175 | 64 | 5 | a9f88054e2c28d604c65ed785f63021aadb7f4c8 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-06 | 178 | 64 | 5 | 27497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-06 | 178 | 64 | 5 | d348a9550db940d204706529759dc51e30506b5f | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 6.11e-06 | 180 | 64 | 5 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.44e-06 | 182 | 64 | 5 | 1d37c486173cc4629842893ddd5033987c04086f | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.44e-06 | 182 | 64 | 5 | e9fcae9d03a6faf85b91882c5da699037bc61aeb | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.44e-06 | 182 | 64 | 5 | aef67bdc6937b315522d39959e26c9b0acf7ab52 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.44e-06 | 182 | 64 | 5 | 087c9f88daf08f5d688b728c2386f91f210d2255 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.62e-06 | 183 | 64 | 5 | bd78e5c2670e67b4363078e3ca5a5b7081d24b7e | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.62e-06 | 183 | 64 | 5 | d1bf3abf42eb9d7facf775becf1338d1faadd647 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.97e-06 | 185 | 64 | 5 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.35e-06 | 187 | 64 | 5 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.54e-06 | 188 | 64 | 5 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.54e-06 | 188 | 64 | 5 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.54e-06 | 188 | 64 | 5 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.14e-06 | 191 | 64 | 5 | 9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.35e-06 | 192 | 64 | 5 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | Control-Myeloid-MoAM4|Myeloid / Condition, Lineage and Cell class | 8.78e-06 | 194 | 64 | 5 | 7ab808dd1876b0eec2831caa16d04fd859b1dc50 | |
| ToppCell | Control-Myeloid-Migratory_DC|Control / Condition, Lineage and Cell class | 8.78e-06 | 194 | 64 | 5 | 374076e60dcee83eb1814aa6b55b77668909f40b | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.78e-06 | 194 | 64 | 5 | ca1f24070424b44b7a442e4fca761ebfbe24b063 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 8.78e-06 | 194 | 64 | 5 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.00e-06 | 195 | 64 | 5 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | Control-Myeloid-Migratory_DC|Myeloid / Condition, Lineage and Cell class | 9.00e-06 | 195 | 64 | 5 | 9f1ad04abc6a6c5e093ea24b60732871b1fad5a4 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.00e-06 | 195 | 64 | 5 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | distal-Hematologic-Interstitial_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.23e-06 | 196 | 64 | 5 | e4f40274df940e0996c555082f2bb4f99e5b0881 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.93e-06 | 199 | 64 | 5 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.02e-05 | 200 | 64 | 5 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-cDC|COVID-19_Severe / Disease, condition lineage and cell class | 1.02e-05 | 200 | 64 | 5 | e7b808d8ed65343a4345fafb03015fe4f7ce302f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-05 | 200 | 64 | 5 | 851c57187db8bc91a393655bca5f13e787a723d4 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.17e-05 | 125 | 64 | 4 | 6cd741dd1c7ee6b16437cca7c15c99b5c95603fc | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.37e-05 | 127 | 64 | 4 | 5b0adbcafad31a6759c9bdce2f7f9591a8edc450 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-DC2|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.94e-05 | 140 | 64 | 4 | c3331cb7720f93af8bab35d02c6cbe87dd324d91 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.36e-05 | 143 | 64 | 4 | 5a279da1cd8e63db32f7c85a73b493c2121d0a96 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.51e-05 | 144 | 64 | 4 | 7de962346ba9653d90dd13bb7d977fe44d200bba | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.66e-05 | 145 | 64 | 4 | 997bd540c43725a85ca97e4b79ebe0d336860287 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.81e-05 | 146 | 64 | 4 | 47368f981180ca6a8c81a50f7f9430f12456f609 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.15e-05 | 154 | 64 | 4 | dd3d34f065820e706515a13619f19a5b12734c8e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.15e-05 | 154 | 64 | 4 | 4bfda1c41efbb86d829b3797d1168bf2587c3c97 | |
| ToppCell | severe_COVID-19-cDC|World / disease group, cell group and cell class (v2) | 7.51e-05 | 156 | 64 | 4 | 0a7e18ed8e13261c405eb6b9a183e99d8e1aac37 | |
| ToppCell | Transverse-Dendritic_cell-cDC2|Dendritic_cell / Region, Cell class and subclass | 7.60e-05 | 57 | 64 | 3 | 8d1ee7e3cfea05418f3a64edc07a76f3cbb1a471 | |
| ToppCell | 367C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.70e-05 | 157 | 64 | 4 | f511871e1a004c6e9af08ee325ab1bfc41807487 | |
| ToppCell | severe_COVID-19-cDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 7.70e-05 | 157 | 64 | 4 | ec1978e07e2214048d015d8bb793c1d9991f6e37 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-05 | 158 | 64 | 4 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-05 | 158 | 64 | 4 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 8.09e-05 | 159 | 64 | 4 | b3c52908cd24bbf851fac69db3850fc7f53c2092 | |
| ToppCell | Basal_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 8.29e-05 | 160 | 64 | 4 | b223cc47e68a29df4758c5ccf8f6dbffe2a6fa1d | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.12e-05 | 164 | 64 | 4 | f4de9f18134a06f3d7fcf5b50b8e21c1506e2083 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Basophil|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.12e-05 | 164 | 64 | 4 | dc22b1fef49c1557a0b63c536eaba574dfcab715 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.78e-05 | 167 | 64 | 4 | 17c653b46507c8bb85da95836ae72a6015336142 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.00e-04 | 168 | 64 | 4 | f3879a8e11eaf866f37c52e67021be43f0b8784a | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-04 | 169 | 64 | 4 | b23d0aaa2da333b9c69a7aee862d5a5d2a1bf79b | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 1.02e-04 | 169 | 64 | 4 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-04 | 169 | 64 | 4 | 83d1bcf33872b01ea9614f608a3e4ab30df25c7e | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-04 | 169 | 64 | 4 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.07e-04 | 171 | 64 | 4 | 5efd15300f865ebf651e0888265cbd717bc3b9d3 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-04 | 171 | 64 | 4 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 172 | 64 | 4 | bc3ed05fdd94d5e1f19285aea867b1453292baec | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 172 | 64 | 4 | 1b133be191252e7053faeacf9547730c3ae28d21 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 1.10e-04 | 172 | 64 | 4 | 38d17e769fe8eac8b57b820490d4ddd969243ee7 | |
| ToppCell | facs-GAT-Fat-18m-Lymphocytic-T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 172 | 64 | 4 | 17a486c5d0430abb133eab9f087e2ef8b60f7d25 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 172 | 64 | 4 | b3c53fd7e50f36de6a8585ae21d04e17932f262c | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 173 | 64 | 4 | 4f849d236ee358ad30ac977745ac43c8e9778e94 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 173 | 64 | 4 | 39c3b8313354c4c60764597507a2505dcfa4e8c7 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.15e-04 | 174 | 64 | 4 | 009e88a6c79689a5d88b0af50aa89aa03b33f800 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 1.15e-04 | 174 | 64 | 4 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.15e-04 | 174 | 64 | 4 | e9e4532a474b4b0938a50ff85c9508aca53cd3ae | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.17e-04 | 175 | 64 | 4 | c58a1f02d1e559d3638fe1500e960e82a8a7187b | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 175 | 64 | 4 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-04 | 177 | 64 | 4 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 177 | 64 | 4 | aa56129d2d5a73a10e33b7162233a4d9337ee535 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 1.22e-04 | 177 | 64 | 4 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-Migratory_DCs_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 177 | 64 | 4 | d78a6003ce2d15d7771ae385de252eec7e3c3eea | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 177 | 64 | 4 | 70ca5b6fde2e38af1eb88a7d6e8746edba298191 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.22e-04 | 177 | 64 | 4 | 59726bfd98f656fdcedf448a7e2e76a9bfad8285 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-04 | 177 | 64 | 4 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | (5)_Dendritic_cell-(50)_cDC2|(5)_Dendritic_cell / shred on Cell_type and subtype | 1.23e-04 | 67 | 64 | 3 | 41566121ac0e97a7df4fc83fc196160b700d3639 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 178 | 64 | 4 | 41745a589567ca5ea6d06331f4c8da03595b5f5c | |
| ToppCell | ASK440-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.25e-04 | 178 | 64 | 4 | 86f1741636ed3e85bb4a65f84949b718fc38c290 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 178 | 64 | 4 | eb940dd64c973f68bcaad6069d3bd56383329db5 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-04 | 179 | 64 | 4 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.28e-04 | 179 | 64 | 4 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-04 | 180 | 64 | 4 | 62511d76d24b836839c3dcc2bf30485ffe9401e2 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Brain / Location, Cell class and cell subclass | 1.31e-04 | 180 | 64 | 4 | 51727cb66fe7a7709453f7026e0ff3d6c93d5aa5 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-04 | 180 | 64 | 4 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Dendritic_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 180 | 64 | 4 | 5b7d2336ed09d07f6b8dd91c1fa9c5ade633c104 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 181 | 64 | 4 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-04 | 181 | 64 | 4 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 181 | 64 | 4 | 6730e249cac55ae892cc567d9211615882f3dab4 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs|tumor_Lung / Location, Cell class and cell subclass | 1.36e-04 | 182 | 64 | 4 | 243779ba1009097f8fafa1a691e296ec3aeefc04 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.36e-04 | 182 | 64 | 4 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-04 | 182 | 64 | 4 | 03992d0ae519795239e4f2cc8e63f33c4482de6a | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.39e-04 | 183 | 64 | 4 | 06e4b05d86a7d643569e19575c2c9aa351d33f29 | |
| Drug | Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; PC3; HT_HG-U133A | 1.70e-05 | 196 | 63 | 6 | 4342_UP | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.80e-05 | 198 | 63 | 6 | 6001_UP | |
| Drug | Deferoxamine mesylate [138-14-7]; Up 200; 6uM; MCF7; HT_HG-U133A | 1.80e-05 | 198 | 63 | 6 | 3842_UP | |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Up 200; 9.8uM; PC3; HT_HG-U133A | 1.80e-05 | 198 | 63 | 6 | 4609_UP | |
| Drug | Isometheptene mucate; Up 200; 8.2uM; MCF7; HT_HG-U133A | 1.91e-05 | 200 | 63 | 6 | 5502_UP | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 4.49e-06 | 2 | 63 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | Cerebral Small Vessel Diseases | 4.47e-05 | 5 | 63 | 2 | C2733158 | |
| Disease | Drug habituation | 1.09e-04 | 115 | 63 | 4 | C0013170 | |
| Disease | Substance-Related Disorders | 1.09e-04 | 115 | 63 | 4 | C0236969 | |
| Disease | Drug abuse | 1.09e-04 | 115 | 63 | 4 | C0013146 | |
| Disease | Drug Use Disorders | 1.09e-04 | 115 | 63 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.09e-04 | 115 | 63 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.09e-04 | 115 | 63 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.09e-04 | 115 | 63 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.09e-04 | 115 | 63 | 4 | C0029231 | |
| Disease | Prescription Drug Abuse | 1.09e-04 | 115 | 63 | 4 | C4316881 | |
| Disease | Substance abuse problem | 1.13e-04 | 116 | 63 | 4 | C0740858 | |
| Disease | Papillary Renal Cell Carcinoma | 1.65e-04 | 128 | 63 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.65e-04 | 128 | 63 | 4 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.65e-04 | 128 | 63 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.65e-04 | 128 | 63 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.65e-04 | 128 | 63 | 4 | C1266044 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.88e-04 | 148 | 63 | 4 | C0279702 | |
| Disease | Moyamoya Disease | 5.98e-04 | 17 | 63 | 2 | C0026654 | |
| Disease | thyroxine measurement, triiodothyronine measurement | 5.98e-04 | 17 | 63 | 2 | EFO_0005130, EFO_0008392 | |
| Disease | triacylglycerol 56:3 measurement | 6.71e-04 | 18 | 63 | 2 | EFO_0010430 | |
| Disease | macula measurement | 7.23e-04 | 189 | 63 | 4 | EFO_0008375 | |
| Disease | Pancreatic carcinoma | 7.49e-04 | 19 | 63 | 2 | C0235974 | |
| Disease | activities of daily living score measurement | 9.18e-04 | 21 | 63 | 2 | EFO_0008451 | |
| Disease | Arthrogryposis | 9.18e-04 | 21 | 63 | 2 | C0003886 | |
| Disease | Adenocarcinoma of lung (disorder) | 9.96e-04 | 206 | 63 | 4 | C0152013 | |
| Disease | Neoplasm Metastasis | 1.21e-03 | 217 | 63 | 4 | C0027627 | |
| Disease | colon adenocarcinoma (is_marker_for) | 1.30e-03 | 25 | 63 | 2 | DOID:234 (is_marker_for) | |
| Disease | pancreatic cancer (is_implicated_in) | 1.79e-03 | 112 | 63 | 3 | DOID:1793 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EVKFSWFMPSAPYWI | 106 | P05090 | |
| YWMPKWINATDPSAR | 536 | P08243 | |
| WAPVMCWDRYPNQTL | 161 | Q9HA82 | |
| IPFKDMWPDDSYWFP | 111 | P36639 | |
| PVSLWANPKYVRAWK | 201 | P54687 | |
| NPWQASYIVPLVWCM | 156 | P50052 | |
| EIQEWTSKPMYRRWW | 221 | O75909 | |
| SCEWPLYMWPFQKPN | 201 | P06280 | |
| VWYPMTGWKSSIIPQ | 196 | Q8TDJ6 | |
| LQEMVLWAPYRPVVW | 3841 | Q96M86 | |
| RPWALMEQYEVVLPW | 21 | P78325 | |
| PWTVYAMNWSVRPDK | 16 | P61962 | |
| KDGNVKSWYPSPMWS | 871 | Q76M96 | |
| AWKYWEVSRLSMPPF | 621 | Q7RTW8 | |
| FWYPKWEMPRPVVCD | 236 | Q4G1C9 | |
| SPSIAWTYPLSMWRE | 281 | A6NDA9 | |
| LSSVPSMRPYLWWKK | 186 | Q9NYP7 | |
| TVPSIVYMPHIGDWW | 826 | Q9ULI0 | |
| SYPRIWNMPQTWQCE | 466 | Q2LD37 | |
| DSATKTFPNWMENPW | 121 | P29323 | |
| VVPTDPWFSKQWYMN | 116 | Q6UW60 | |
| AQSTYFNDPKWPSMW | 121 | Q92824 | |
| KPLRWMDWNAPQVQY | 736 | P32004 | |
| MALPRCTWPNYVWRA | 1 | Q8N2Q7 | |
| VVCMLQFPSPSWYWD | 196 | P41143 | |
| WKLNFRWYPVPQREM | 261 | Q10472 | |
| HVSGFYPKPVWVMWM | 231 | P15812 | |
| RMYPLKVTWWFCAFP | 976 | P50993 | |
| WIQDPDGSWYAMTRK | 251 | O75054 | |
| EEWLPSPSGMWYKRA | 921 | O75054 | |
| KYFVTRWSTDPWIQM | 751 | Q8NB78 | |
| HASGFYPKPVWVTWM | 226 | P29017 | |
| YPKPVWVTWMRNEQE | 231 | P29017 | |
| MTSWAIVCSVWYLPP | 376 | Q86UL3 | |
| WSIKNPMWPERIYQS | 521 | Q5VTH9 | |
| PYRLVWQSKVGPMPW | 296 | P22830 | |
| NTQSYWIWLEPMKPI | 91 | O94887 | |
| TMEWNRWPVSYADRK | 91 | Q8TB52 | |
| TSLWLRWMPLPEMEY | 1111 | Q58EX2 | |
| PRTDLWVYKPAQNSW | 401 | Q86V97 | |
| SPVMTPQFKFWAWDP | 756 | Q9UPQ0 | |
| PMPWTVNSEIYPLWA | 526 | Q96QE2 | |
| YWKPVLSMDANSWQR | 561 | Q5T011 | |
| TIQWWNMPSPSVDPY | 556 | Q13033 | |
| KQYRWMEWNPGFPLS | 141 | P09917 | |
| MQDYAWTPKEAPWRL | 1236 | O95255 | |
| YGSWRMHTKIVPPWA | 256 | Q9BRJ2 | |
| AMWPEQSDKWPTAVR | 691 | Q9P2J5 | |
| YGRRAPWEDPAKWVM | 2381 | Q8IVL1 | |
| AKWVMDTYPWAASPQ | 2391 | Q8IVL1 | |
| PPAWPDYDVWILMTV | 191 | Q68DV7 | |
| YMAIPSPLVAVEWWR | 801 | Q149N8 | |
| RWTSPDYTMWKNVGK | 2436 | Q9NT68 | |
| LSWMDWLKQTYPPEH | 166 | P42338 | |
| WYIMEKWAPLASPMQ | 191 | Q7Z745 | |
| DTMYEVLVPFWPWLA | 541 | Q7RTU9 | |
| PSPDYFTWNLTWIMK | 236 | Q9UM73 | |
| TRIPYCPKWSMEALW | 1561 | Q9BXT8 | |
| MWHPYKVDVTWTRAR | 251 | Q9Y2B4 | |
| KMWNPREPRDWAQQY | 56 | Q96AN5 | |
| KTYAPSFIWVEMWPL | 711 | Q9HBX9 | |
| KYTWSWGSPDILPMF | 131 | O95427 | |
| KAETNMVWYDWMRPS | 196 | Q9NQH7 | |
| DTMYEVLVPFWPWLA | 541 | A6NGW2 | |
| DYPWRWSRAVPMNSA | 1066 | Q92508 | |
| EWWAETLRPYQSPFM | 601 | Q01831 | |
| MWSIWPELPAYGRKA | 3451 | Q5T4S7 | |
| YARDKWWPSDPQIIS | 526 | Q9HCX4 |